BeStock  
Markets › Compare › HALO vs CORT

HALO vs CORT

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
HALO · Halozyme Therapeutics$106.94 ▼ 3.13%
CORT · Corcept Therapeutics$114.00 ▼ 1.07%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

306599134168Oct 2, '25Apr 1, '26Sep 30, '26
  • HALO +54.0%
  • CORT +34.8%

Head to head

MetricHALOCORT
Price$106.94$114.00
Change today▼ 3.13%▼ 1.07%
Market cap$12.14B$12.32B
Return, 3 months+38.9%+28.8%
Return, year to date+58.9%+227.6%
Return, 1 year+42.7%+35.3%
P/E (TTM)31.4253.3
P/B84.517.5
P/E percentile vs own 5y––
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price-2.9%+23.7%
Analyst buy share83%80%
RSI (14)5553
30-day volatility24.9%35.0%
Max drawdown, 1 year-24.1%-64.4%
Trend readLeaning bullishStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CORT is the largest of the group by market value.
  • HALO has returned the most over the past year.
  • HALO carries the lowest trailing P/E.
  • HALO has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top